Phase II trial of rituximab and autologous stem cell transplantation for refractory B cell large cell lymphoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carmustine; Cyclophosphamide; Etoposide; Filgrastim; Rituximab
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 28 Sep 2017 Biomarkers information updated
- 25 Jan 2012 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
- 25 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.